Tanzania
+918770708752

Vinorelbine Injection Supplier Guide for Healthcare Procurement in Dodoma

A safe vinorelbine purchase requires more than confirming a 50 mg vial and a quoted price. By the end, you will have a practical way to verify the medicine, qualify the legal supply chain, review the shipment, and prevent a cytotoxic injectable from entering stock without the required evidence.

Key takeaways

  • Confirm TMDA authorisation for the exact indication and presentation.
  • Ask for supplier licences, product documents and the Tanzania distribution route.
  • Set temperature, delivery, inspection and rejection controls before ordering.
  • Compare usable cost, wastage risk and purchase-order terms—not unit price alone.

Confirm the medicine, indication and exact presentation

Confirm that the product is authorised for the intended cancer indication in Tanzania before comparing quotations. Vinorelbine is used in specified oncology regimens, including certain non-small-cell lung and breast cancers, but an indication approved in another country is not automatically approved by the Tanzania Medicines and Medical Devices Authority (TMDA).

Off-label use requires the hospital’s clinical and regulatory approval.

1. Match the generic name and salt: check whether the label states vinorelbine or vinorelbine tartrate, and whether the stated amount is equivalent to vinorelbine.

2. Match the strength and fill: verify 10 mg/mL, 50 mg total content, 5 mL volume, and the concentration printed on the vial. “Vinorelbine 50 mg wholesale” identifies the amount per vial, not the carton quantity; confirm vials per carton and total volume separately.

3. Check the presentation: record the brand name, excipients, storage wording, and whether the container is single-dose or multidose.

4. Identify the legal manufacturer, manufacturing site, marketing authorisation holder, batch-release site, and importer or local representative. Confirm that this exact product and presentation has acceptable TMDA registration status.

Do not compare a quotation until its label, indication, registration details and presentation match your purchase specification. Ask for cytotoxic spill and extravasation instructions, because vinorelbine can injure tissue if it escapes the vein.

Qualify the supplier and Tanzania distribution route

A Dodoma buyer can distinguish an authorized vinorelbine injection supplier by tracing responsibility from the manufacturer to the Tanzanian receiving facility, not by accepting a branded quotation. Treat a search for “vinorelbine injection for pharmaceutical supplier in dodoma” as a TMDA and distribution check.

Ask the quoted supplier to identify:

  • The legal manufacturer, manufacturing site and marketing authorisation holder
  • The exact vinorelbine strength and presentation registered or accepted by TMDA
  • The Indian exporter, Tanzanian importer and authorised local distributor
  • The batch-release party and temperature-controlled carrier
  • The organisation responsible for pharmacovigilance, complaints, recalls and cytotoxic spill guidance

Request the manufacturer’s manufacturing authorisation, GMP evidence, Certificate of Pharmaceutical Product where applicable, and a recent batch Certificate of Analysis covering sterility and bacterial endotoxins. These documents qualify the manufacturer; they do not replace Tanzanian authorization for the specific product.

If NIBA HEALTHCARE is proposed as the vinorelbine injection supplier, request the same evidence and confirm its named Tanzania distribution route before issuing a purchase order. Reject quotations that hide the manufacturer, provide only a pro forma invoice, or describe vinorelbine as an ordinary injectable without IV-only and intrathecal-error warnings.

Related product

Vinorelbine 50 Mg Injection

Anti Cancer Injection

Vinorelbine 50 Mg Injection

minimum order quantity 10 Vial Strength 50 mg Form Injection Usage/Application Clinic Composition Vinorelbine injection 50 mg Storage Condition Store...

View product →

Build the procurement dossier before placing an order

Before approving vinorelbine procurement, obtain a dossier that identifies the legal manufacturer, manufacturing site, batch-release site, exporter, importer and Tanzanian distributor. Confirm that the exact strength and presentation is authorized or acceptable to the Tanzania Medicines and Medical Devices Authority (TMDA); a quotation alone proves nothing.

DocumentWhat to requestWhat it confirms
ManufacturerManufacturing authorization, current GMP certificate, Certificate of Pharmaceutical Product where applicableThe plant is licensed and the product has a defined regulatory source
ProductApproved product information, composition, strength, vial fill, storage conditions and “IV use only” warningThe quoted medicine matches the approved presentation and prevents intrathecal-error risk
BatchCertificate of Analysis, batch-release certificate, manufacture and expiry dates, batch number, sterility and bacterial-endotoxin resultsThis specific lot passed release testing
RegulatoryTMDA registration or written authorization, marketing-authorisation-holder details, importer and local representative informationThe supply route is legally accountable in Tanzania
SafetyDose-modification, blood-count monitoring, cytotoxic-handling and pharmacovigilance instructionsOncology staff receive the information needed for safe use and reporting
CommercialPro forma invoice, packing list, certificate of origin, insurance, temperature records, recall contacts and replacement termsPrice, custody, traceability and remedy are clear

Reject mismatched names, altered certificates, missing batch data or documents issued only by an intermediary. Put minimum remaining shelf life, cold-chain responsibilities and recall cooperation into the purchase order.

Set cold-chain, delivery and receiving controls

Write the purchase order for a refrigerated cytotoxic injectable, not a routine medicine. Identify the vinorelbine salt, strength, concentration, vial volume, manufacturer, batch-release site, importer and local representative.

Confirm that the specific product and route are acceptable to the Tanzania Medicines and Medical Devices Authority before shipment; a vinorelbine injection supplier that only quotes stock is not necessarily the authorized source for vinorelbine procurement.

Specify these controls in the order:

  • Maintain 2–8 °C throughout transport; do not freeze the vials.
  • Use light-protective, validated packaging sized for the consignment.
  • Provide a temperature logger or complete temperature record with the shipment.
  • Report every excursion immediately and follow a written disposition procedure.
  • State the minimum remaining shelf life required at Dodoma arrival.
  • Record batch numbers, quantities and replacement responsibility for damaged or rejected stock.
  • Mark the consignment “cytotoxic” and “IV use only”; require a prominent warning against intrathecal administration.

At receipt, trained pharmacy staff should photograph the carton, inspect seals, labels, vials and coolant damage, and compare batch numbers and quantities with the invoice and packing list.

Quarantine the shipment before clinical release if the logger is missing, the temperature is outside 2–8 °C, a vial is frozen, light protection is damaged, or traceability is incomplete. Keep it segregated, document the decision, and obtain written manufacturer or supplier disposition before release or replacement.

Keep preparation and administration with oncology-trained staff

Preparation and administration must remain with oncology-trained healthcare professionals. For vinorelbine procurement, require the supplier to provide the approved product label and prescribing information so staff do not infer clinical instructions from the vial strength, concentration or carton.

The accompanying documentation should state:

  • Vinorelbine is a cytotoxic vinca-alkaloid for intravenous use only; it must never be administered intrathecally.
  • The approved dilution options are 20–50 mL of 0.9% sodium chloride or 5% dextrose, with compatibility instructions for the supplied presentation.
  • Administration takes approximately 6–10 minutes, followed by flushing of the vein, as specified in the product information.
  • A blood count is required before each dose, with the approved dose-modification and monitoring instructions included.
  • The label must identify extravasation, cytotoxic-handling, accidental-exposure and disposal precautions.

Require prominent “IV use only” and intrathecal-error warnings on the pack and shipping documents. Ask for the approved indication, contraindications, excipients and single-dose or multidose status, then route the documents to the oncology pharmacist or prescriber for review.

These controls support safe clinical use; they do not replace the treating team’s prescription, assessment or administration protocol.

Compare usable cost, wastage and purchase-order terms

A 50 mg vial quotation is not the usable cost. At the common 10 mg/mL concentration, it contains 5 mL, but confirm the salt, concentration, fill volume, single-dose status, and carton quantity before comparing offers. “vinorelbine 50 mg wholesale” describes strength per vial, not case size.

ComparisonQuoted basisDecision rule
Vial pricePrice for one 50 mg vialCompare only after confirming carton count, delivery, taxes and cold-chain charges
Usable dose costPrice divided by doses actually administeredAdd expected discard from restricted in-use stability and dose rounding
Shared-vial costSeveral patients supplied from one opened vialUse only under approved aseptic procedures; reject assumed savings if sterility controls or scheduling are inadequate
Expiry valueVials remaining at deliverySet a minimum remaining shelf life and exclude stock that cannot be used before expiry

Put these terms on the purchase order:

  • State “IV use only” and require prominent cytotoxic and intrathecal-error warnings on packs and shipping documents.
  • Name the manufacturer, presentation, batch, expiry, carton quantity and agreed unit price; prohibit substitution without written approval.
  • Require replacement or credit for temperature excursions, leakage, damaged seals, wrong product or short expiry.
  • Require the approved label, compatibility instructions and blood-count, dose-modification and monitoring information with each shipment.
  • Make payment conditional on receiving complete documents and passing quarantine inspection.

Frequently asked questions

  • How do you confirm vinorelbine injection is suitable for procurement in Tanzania?

    Check TMDA authorisation for the exact product, strength, dosage form and intended oncology indication before comparing quotations.

  • What should you verify about a vinorelbine injection supplier in Dodoma?

    Request the supplier’s licence details, product authorisation documents, batch information and a clear route for delivery into Tanzania.

  • Which documents belong in a vinorelbine procurement dossier?

    Compile the quotation, product specification, registration evidence, batch and expiry details, certificates, purchase order and delivery requirements.

  • What controls should apply when receiving vinorelbine injection?

    Agree temperature records, packaging inspection, delivery timing, batch and expiry checks, and rejection procedures before shipment.

  • Who should prepare and administer vinorelbine injection?

    Keep preparation and administration with oncology-trained staff who follow the approved product information and local clinical protocols.

 2026-10-14T03:00:18

Keywords